Biohaven Ltd. financial data

Symbol
BHVN on NYSE
Location
215 Church Street, New Haven, CT
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % -20%
Debt-to-equity 154 % +270%
Return On Equity -390 % -73.2%
Return On Assets -153 % +3.42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 106M shares +4.68%
Common Stock, Shares, Outstanding 106M shares +11.5%
Entity Public Float 2.24B USD +127%
Common Stock, Value, Issued 1.74B USD +26.2%
Weighted Average Number of Shares Outstanding, Basic 106M shares +12.1%
Weighted Average Number of Shares Outstanding, Diluted 106M shares +12.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 681M USD -10.8%
General and Administrative Expense 112M USD +30.7%
Costs and Expenses 793M USD -6.63%
Operating Income (Loss) -793M USD +6.63%
Nonoperating Income (Expense) 13.6M USD -69.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -779M USD +3.22%
Income Tax Expense (Benefit) 1.14M USD
Net Income (Loss) Attributable to Parent -780M USD +3.01%
Earnings Per Share, Basic -7 USD/shares +20.5%
Earnings Per Share, Diluted -7 USD/shares +20.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 185M USD +119%
Marketable Securities, Current 75.4M USD -74.4%
Other Assets, Current 8.42M USD +602%
Assets, Current 324M USD -26.5%
Property, Plant and Equipment, Net 17.5M USD -4.13%
Operating Lease, Right-of-Use Asset 45.2M USD +56.4%
Intangible Assets, Net (Excluding Goodwill) 18.4M USD 0%
Goodwill 1.39M USD 0%
Other Assets, Noncurrent 48.2M USD +50.8%
Assets 409M USD -19.9%
Accounts Payable, Current 17.5M USD -11.4%
Employee-related Liabilities, Current 18.2M USD +14.6%
Accrued Liabilities, Current 73.5M USD +15.7%
Liabilities, Current 113M USD -25.8%
Operating Lease, Liability, Noncurrent 40.4M USD +59.6%
Other Liabilities, Noncurrent 4.6M USD +0.11%
Liabilities 426M USD +119%
Accumulated Other Comprehensive Income (Loss), Net of Tax 36K USD -74.3%
Retained Earnings (Accumulated Deficit) -1.94B USD -67.3%
Stockholders' Equity Attributable to Parent -17.2M USD -105%
Liabilities and Equity 409M USD -19.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -165M USD -60.9%
Net Cash Provided by (Used in) Financing Activities 369K USD -89.2%
Net Cash Provided by (Used in) Investing Activities 165M USD +384%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 106M shares +11.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 147K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 188M USD +114%
Deferred Tax Assets, Valuation Allowance 304M USD +17.1%
Operating Lease, Liability 36.6M USD +18.5%
Depreciation 4.19M USD +8.25%
Payments to Acquire Property, Plant, and Equipment 461K USD +4.77%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -780M USD +3%
Lessee, Operating Lease, Liability, to be Paid 49.3M USD +23.9%
Operating Lease, Liability, Current 5.51M USD +49.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.18M USD +29.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.14M USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.7M USD +42.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.84M USD +19.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.3M USD +4.55%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.33M USD +18.1%
Additional Paid in Capital 178M USD +91.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.25M USD +55.3%
Deferred Tax Assets, Net of Valuation Allowance 8.42M USD +11.9%